News

ExoProTher – Investor Forum at the World Stem Cell Summit

Health
0 min read

ExoProTher Co-Founder and CEO Dr. Lana Volokh delivers a formal corporate overview, followed by a Q & A session moderated by a Noble Capital Markets equity research representative.

Return to the Investor Forum Event Page

ExoProTher Medical is a preclinical stage company developing a first in class oncology therapeutic platform targeting cancers with mutation in gene TP53 – the most frequently observed genetic alterations in human cancer.

Share

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy